Recently, Ferreira et al. evaluated liver fibrosis before and after DAA-induced HCV clearance and found that the reduction in liver fibrosis after DAA treatment was associated with a specific TNFα and IL10 genotype. This evidence concerns the gene IL10 and Hepatic fibrosis.